NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,442,939 | -3.2% | 107,504 | -1.4% | 1.22% | +1.5% |
| Q2 2023 | $10,791,190 | -2.9% | 109,057 | -8.3% | 1.20% | -11.1% |
| Q1 2023 | $11,115,052 | +6.4% | 118,903 | +5.0% | 1.35% | +1.4% |
| Q4 2022 | $10,447,136 | +29.8% | 113,199 | +7.0% | 1.33% | +13.4% |
| Q3 2022 | $8,046,000 | -0.7% | 105,813 | +9.3% | 1.17% | -2.7% |
| Q2 2022 | $8,105,000 | -0.5% | 96,805 | +7.8% | 1.21% | +8.2% |
| Q1 2022 | $8,144,000 | +22.9% | 89,837 | +21.8% | 1.12% | +23.6% |
| Q4 2021 | $6,624,000 | +31.0% | 73,767 | +19.3% | 0.90% | +11.5% |
| Q3 2021 | $5,056,000 | -8.3% | 61,827 | +2.3% | 0.81% | -12.2% |
| Q2 2021 | $5,516,000 | +22.0% | 60,460 | +15.8% | 0.92% | +9.5% |
| Q1 2021 | $4,521,000 | +6.8% | 52,194 | +16.4% | 0.84% | -12.8% |
| Q4 2020 | $4,234,000 | +25.3% | 44,836 | +15.3% | 0.96% | +5.2% |
| Q3 2020 | $3,380,000 | +9.0% | 38,871 | +9.5% | 0.92% | -10.9% |
| Q2 2020 | $3,100,000 | – | 35,491 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |